B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.
about
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia.Revisiting the role of interleukin-8 in chronic lymphocytic leukemia.Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples.
P2860
B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
B cells and macrophages pursue ...... chronic lymphocytic leukemia.
@en
type
label
B cells and macrophages pursue ...... chronic lymphocytic leukemia.
@en
prefLabel
B cells and macrophages pursue ...... chronic lymphocytic leukemia.
@en
P2093
P2860
P356
P1433
P1476
B cells and macrophages pursue ...... chronic lymphocytic leukemia.
@en
P2093
F Caligaris-Cappio
G Galletti
M T S Bertilaccio
P2860
P2888
P304
P356
10.1038/LEU.2016.261
P577
2016-09-28T00:00:00Z
P6179
1020174299